K. Albertsson

发表

Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis

A. Boonen, I. Hafström, B. Svensson, 2009, Scandinavian journal of rheumatology.

The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years

C. Turesson, I. Petersson, J. Nilsson, 2011, Scandinavian journal of rheumatology.

Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood.

L. Klareskog, Lars Klareskog, L. Berg, 1998, British journal of rheumatology.

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage

M. Ahlmén, I. Hafström, B. Svensson, 2009, Annals of the rheumatic diseases.

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

S. Saevarsdottir, P. Geborek, S. Ernestam, 2011, Annals of the rheumatic diseases.

Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis

I. Hafström, M. Bokarewa, A. Tarkowski, 2010, Annals of medicine.

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.

A. Boonen, I. Hafström, C. Keller, 2005, Arthritis and rheumatism.

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial

S. Saevarsdottir, P. Geborek, I. Petersson, 2014, Annals of the rheumatic diseases.

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

P. Geborek, I. Petersson, S. Ernestam, 2012, The Lancet.

Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study

D. M. van der Heijde, A. Boonen, R. Landewé, 2008, Annals of the rheumatic diseases.

Joint destruction in early rheumatoid arthritis over 8 years is similar in women and men despite apparently higher disease activity and poorer function in women

I. Hafström, B. Svensson, K. Forslind, 2010, Annals of the rheumatic diseases.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis

D. Heinegård, I. Hafström, T. Saxne, 2013, BMC Musculoskeletal Disorders.